Nicotinamide Riboside Supplementation Reduces Oxidative Stress and Enhances Mitochondrial Function in Chronic Kidney Disease Immune Cells: Clinical Findings
Objectives
To investigate the effects of NR and CoQ10 on oxidative stress, inflammation, and mitochondrial function in patients with chronic kidney disease (CKD).
Journal
Clinical Journal of the American Society of Nephrology
Key Outcomes
- NR supplementation primarily affected gene activity related to carbohydrate/fat metabolism and immune signaling, while CoQ10 influenced genes linked to immune/stress response and fat metabolism.
- Both NR and CoQ10 reduced plasma oxidative stress markers, but their effects on inflammation markers differed. NR showed mixed results, whereas CoQ10 consistently reduced inflammation.
- Only NR improved mitochondrial function in monocytes, a type of white blood cell.
Duration
6 weeks
Dose
1000 mg*
*Patients were given NR (1000mg) or CoQ10 (1200 mg).
Study Design
Randomized, double-blind, placebo-controlled, crossover study in 25 chronic kidney disease (CKD) patients